Home › Funds › Trails Edge Capital Partners, LP › IVA

Trails Edge Capital Partners, LP position in IVA

INVENTIVA SA · Health Care

Trails Edge Capital Partners, LP reported holding 2,657,997 shares of IVA (INVENTIVA SA) in its Q2 2026 13F filing — a position valued at US$10.0M, representing 1.60% of its reported portfolio and ranking #26 among its reported holdings. Trails Edge Capital Partners, LP has disclosed IVA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)2.66M sh
Reported value held$10.05M
Portfolio Weight1.60%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's IVA position evolved

Trails Edge Capital Partners, LP first disclosed a stake in IVA in Q4 2025 at 2,657,997 shares (US$12.4M). The position peaked in Q1 2026 at 2,657,997 shares, worth US$14.8M. Across 3 filings, Trails Edge Capital Partners, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,657,997 shares valued at US$10.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.66M $12.36M New
Q1 2026 2.66M $14.75M Hold
Q2 2026 2.66M $10.05M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IVA and 13F data

IVA (INVENTIVA SA) is a Health Care company. 94 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Paradigm Biocapital Advisors LP (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IVA

All IVA fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held IVA?

Trails Edge Capital Partners, LP has disclosed IVA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Trails Edge Capital Partners, LP's current position in IVA?

As of Q2 2026, Trails Edge Capital Partners, LP holds 2.66M shares of IVA (INVENTIVA SA), valued at $10.05M, representing 1.60% of its reported portfolio and ranking #26.

Has Trails Edge Capital Partners, LP been buying or selling IVA?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP held unchanged its position in IVA. The position peaked in Q1 2026 at 2.66M shares.

Which other funds hold IVA?

Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Paradigm Biocapital Advisors LP, among 94 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.